Stop Ovarian Cancer Young; Effect of the Opportunistic Salpingectomy on Age of Menopause
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Salpingectomy
- Sponsor
- Radboud University Medical Center
- Enrollment
- 1200
- Locations
- 1
- Primary Endpoint
- Menopausal age
- Status
- Enrolling By Invitation
- Last Updated
- 2 years ago
Overview
Brief Summary
The aim of this study is to evaluate the long-term safety of on the onset of menopause.
Detailed Description
The aim of this study is to evaluate the long-term safety of on the onset of menopause. To investigate the effect of Opportunistic Salpingectomy on the age of menopause, we will compare age of menopause in women who underwent sterilization through opportunistic salpingectomy with a control group consisting of women who underwent sterilization by tubal ligation or who had no sterilization.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Intervention group
- •Undergoing an Opportunistic Salpingectomy as sterilization method
- •Premenopausal status at enrolment
- •Age between 30 and 45 years
- •Will have residual ovarian tissue after surgery
- •Able to understand the written or spoken Dutch language
- •Gives consent for participating in surveys
- •Control group
- •Premenopausal status at enrolment
- •Either sterilization by tubal ligation or no sterilization at all
Exclusion Criteria
- •Postmenopausal status at enrolment
- •Under the age of 35 or above 45
- •Previous salpingectomy of oophorectomy
- •Previous hysterectomy
- •Women with abnormal karyotype (such as Turner Syndrome and Fragile X syndrome)
- •Underwent chemotherapy or radiation
- •Unable to understand the written or spoken Dutch language
Outcomes
Primary Outcomes
Menopausal age
Time Frame: At end of follow-up (follow up ends at age of menopause with a maximum follow-up time of 15 years)
The age of reaching natural menopause (e.g. last menstruation \> 1 year ago )
Secondary Outcomes
- Decision regret(1 year post surgery and at age of menopause)